Adaily Najeh, Mzabi Anis, Anoun Jihed, Ben Hassine Donia, Melki Sara, Ghannouchi Neirouz, Ben Fredj Fatma
Internal Medicine Department, Sahloul Teaching Hospital, Faculty of Medicine of Sousse, University of Sousse, Tunisia.
Research Lab LR19SP01, Sahloul Teaching Hospital, Faculty of Medicine of Sousse, University of Sousse, Tunisia.
Tunis Med. 2023 May 5;101(5):502-506.
Takayasu's Arteritis (TA) is a systemic vasculitis affecting the aorta and its main branches.
To describe the epidemiological, diagnostic, therapeutic and prognostic profile of TA in the referral departments of internal medicine in the Sousse region (Tunisia).
This is a descriptive, retrospective and exhaustive study, carried out in the two departments of Internal Medicine of Sousse. Patients followed for AT, from 1996 to 2020 were included. The disease was defined according to the classification criteria of the American College of Rheumatology. Disease activity was assessed according to NIH criteria. Age referred to the date of diagnosis.
The study population consisted of 40 patients (Sahloul: n=32, Hached: n=8) with a sex ratio=0.17 and a median age=35 years (IIQ=[30-41]). The median diagnostic delay was 5 months (IIQ=[2-14]). The main clinical sign was pulse abolition and/or decrease (78%). Aortic stenosis was the main arterial lesion found (98%). Treatment was based on corticosteroids (95%) and immunosuppressants (42%). The prognosis of TA was often active (62%), with vascular co-morbidity (60%) and iatrogenic complications (35%).
The epidemiological-clinical profile of AT in the region of Sousse (Tunisia) was characterized by a female predominance, a diagnostic delay, a clinical polymorphism, and evolution towards vascular co-morbidities.
大动脉炎(TA)是一种影响主动脉及其主要分支的系统性血管炎。
描述突尼斯苏塞地区内科转诊科室中TA的流行病学、诊断、治疗和预后情况。
这是一项在苏塞两个内科科室开展的描述性、回顾性和详尽性研究。纳入1996年至2020年期间接受TA治疗的患者。该疾病根据美国风湿病学会的分类标准进行定义。疾病活动度根据美国国立卫生研究院(NIH)标准进行评估。年龄为诊断日期时的年龄。
研究人群包括40例患者(萨赫卢勒医院:n = 32,哈谢德医院:n = 8),性别比为0.17,中位年龄为35岁(四分位间距[30 - 41])。中位诊断延迟为5个月(四分位间距[2 - 14])。主要临床体征为脉搏消失和/或减弱(78%)。主动脉狭窄是主要发现的动脉病变(98%)。治疗以使用糖皮质激素(95%)和免疫抑制剂(42%)为主。TA的预后通常为活动期(62%),伴有血管合并症(60%)和医源性并发症(35%)。
突尼斯苏塞地区TA的流行病学 - 临床特征为女性占主导、诊断延迟、临床多态性以及向血管合并症发展。